TELA Bio shares are trading lower after the company reported worse-than-expected Q2 financial results.
Portfolio Pulse from Benzinga Newsdesk
TELA Bio shares are trading lower after the company reported worse-than-expected Q2 financial results.

August 13, 2024 | 10:23 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TELA Bio shares are trading lower due to the company reporting worse-than-expected Q2 financial results.
The company's worse-than-expected Q2 financial results have directly led to a decline in its share price. Investors are likely reacting negatively to the financial underperformance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100